Press releaseBusiness Wire
Rogers
ROG · NYSE
$136.81+$2.07 (+1.54%)TodayMarket closed ·
Prev close $134.74
Latest news
- News
Rogers Expects FY28 Adjusted EPS Range $5.50 - $6.50, Revenue Range $1B - $1.1B, FY2030 Adjusted EPS Of $14, Revenue $1.5B
- Press releaseBusiness Wire
Rogers Corporation Provides 2030 Financial Targets at 2026 Investor Day
- NewsAvi Kapoor
Hewlett Packard Enterprise, Capital Bancorp, FormFactor And Other Big Stocks Moving Higher On Wednesday
- Press releaseBusiness Wire
Rogers Corporation to Host Investor Day on September 30, 2026
- Press releaseBusiness Wire
Rogers Corporation Announces Investor Day on September 30, 2026
- NewsShomik Sen Bhattacharjee
SpaceX’s Starlink in Focus as FCC Moves to Expand Satellite Broadband Spectrum; To Vote on Sept. 30
- News
Rogers Q2 Adj. EPS $0.92 Misses $0.99 Estimate, Sales $216.800M Beat $215.500M Estimate
- Press releaseBusiness Wire
Rogers Corporation Reports Second Quarter 2026 Results
- Press releaseBusiness Wire
Rogers Corporation Releases Its 2026 Sustainability Report
- Press releaseBusiness Wire
Rogers Corporation Schedules Second Quarter 2026 Earnings Call for July 28
- Press releaseBusiness Wire
Rogers Corporation Appoints Ali El-Haj Chief Executive Officer
- Press releaseBusiness Wire
Rogers Corporation Announces Addition of Brett Cope and Eric Starkloff to Its Board of Directors
- NewsAvi Kapoor
Meta, Ford, Willis Towers Watson And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
- News
Rogers Q1 2026 Earnings Call: Complete Transcript
- News
Rogers Q1 Adj. EPS $0.75 Beats $0.68 Estimate, Sales $200.500M Inline
- Press releaseBusiness Wire
Rogers Corporation Reports First Quarter 2026 Results
- Press releaseBusiness Wire
Rogers Corporation Schedules First Quarter 2026 Earnings Call for April 28
- Press releaseBusiness Wire
ScanSource Announces Appointment of Chief Human Resources Officer
- Press releasePRNewswire
New survey demonstrates how diabetes limits day-to-day freedom for people around the world and highlights need for predictive tools
- Press releaseBusiness Wire
Rogers Corporation Reports Fourth Quarter and Full Year 2025 Results
- News
Rogers Earnings Preview
- Press releaseBusiness Wire
Rogers Corporation Schedules Fourth Quarter 2025 Earnings Call for February 17
- Press releaseBusiness Wire
Rogers Corporation Reports Third Quarter 2025 Results
- Press releaseBusiness Wire
Rogers Corporation Announces Transition of Board Chair and Plans to Add New Independent Director
- Press releaseBusiness Wire
Rogers Corporation Schedules Third Quarter 2025 Earnings Call for October 29
- Press releasePRNewswire
Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
- Press releaseBusiness Wire
Rogers Corporation Reports Second Quarter 2025 Results
- Press releaseBusiness Wire
Rogers Corporation Schedules Second Quarter 2025 Earnings Call for July 31
- Press releaseBusiness Wire
Rogers Corporation Announces CEO Transition
- Press releaseBusiness Wire
Rogers Corporation Reports First Quarter 2025 Results
- Press releaseBusiness Wire
Rogers Corporation Schedules First Quarter 2025 Earnings Call for April 29
- Press releaseBusiness Wire
Rogers Corporation Reports Fourth Quarter and Full Year 2024 Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.